News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NZyme Pharmaceuticals, Inc. Unveils New Patent For Subtilisin NAT Applications In Decreasing Blood Viscosity


7/17/2006 4:32:38 PM

PAGOSA SPRINGS, Colo.--(BUSINESS WIRE)--July 14, 2006--NZyme Pharmaceuticals, Inc. (d/b/a NZyme Pharm) announced today that they have a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease such as heart attacks and ischemic strokes, essential hypertension and deep vein thrombosis.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES